Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

Video

Sequencing Pancreatic Cancer

Sequencing Pancreatic Cancer

The Australian Pancreatic Genome Initiative (APGI) is working to map the genetic blueprint of pancreatic cancer.

Read More…

Building a Pancreatic Cancer genomic databank

A comprehensive pancreatic cancer genomic databank will foster new and more effective ways to treat and manage pancreatic cancer for each individual cancer patient. This is the era of personalised medicine. Broadcast in April 2010.

Read More…

Discovery to aid pancreatic cancer care

Discovery to aid pancreatic cancer care

The Australian discovery of two biomarkers that will help to determine the likely success of risky pancreatic cancer surgery.

Read More…

The International Cancer Genome Consortium

The APGI is a member of the International Cancer Genome Consortium. The Australian contribution is pancreatic cancer and is co-led by the Garvan Institute in Sydney and the Institute of Molecular Bioscience in Brisbane. Our goal is to map the genome of pancreatic cancer in order to provide scientists and doctors tools to discover new ways to treat pancreatic cancer.

Read More…

Garvan's Work in Pancreatic Cancer

Garvan's Work in Pancreatic Cancer

Professor Andrew Biankin talks about Garvan's work in pancreatic cancer.

Read More…

ABC 7:30 Report on the APGI

ABC 7:30 Report on the APGI

Professor Andrew Biankin talks to the 7:30 Report about exciting new developments in pancreatic cancer research in Australia. Broadcast in April 2010.

Read More…

Avner's Story

Avner's Story

This is a documentary on Avner Nahmani Pancreatic Cancer Foundation that details the human story behind the research and nursing work now being pursued. As the most lethal cancer, there is often too little that can be done once diagnosed. This story shows how, with the help of the growing community behind pancreatic cancer research, we are on track to double the survival rate by 2020. Written, produced and narrated by Amy Hosking.

Read More…